Novartis AG (NVS)
NYSE: NVS · Real-Time Price · USD
156.34
+2.13 (1.38%)
At close: Aug 7, 2026, 4:00 PM EDT
156.33
-0.01 (-0.01%)
After-hours: Aug 7, 2026, 4:00 PM EDT
Novartis AG Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 56,693 | 56,674 | 51,722 | 46,660 | 43,461 | 43,974 |
Revenue Growth | 2.73% | 9.57% | 10.85% | 7.36% | -1.17% | -11.87% |
Gross Profit Gross Profit Growth | 42,374 | 42,975 | 38,895 | 34,188 | 31,879 | 32,239 |
Operating Income Operating Income Growth | 17,102 | 17,644 | 14,544 | 9,769 | 7,946 | 10,056 |
Net Income Net Income Growth | 12,757 | 13,984 | 11,941 | 14,850 | 6,955 | 24,021 |
Earnings Per Share EPS Growth | 6.63 | 7.15 | 5.87 | 7.10 | 3.17 | 10.63 |
EPS Growth | -3.35% | 21.81% | -17.32% | 123.97% | -70.18% | 201.99% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cardiovascular, Renal And Metabolic Cardiovascular, Renal And Metabolic Growth | 7,247 | 8,959 | 8,576 | 6,390 | 4,756 | 3,560 |
Immunology Immunology Growth | 10,581 | 10,293 | 9,293 | 7,798 | 7,287 | 7,205 |
Neuroscience Neuroscience Growth | 6,672 | 5,993 | 4,750 | 3,651 | 3,038 | 5,007 |
Oncology Oncology Growth | 17,167 | 16,830 | 14,297 | 12,851 | 11,176 | 10,531 |
Established Brands Established Brands Growth | 13,099 | 12,457 | 13,401 | 14,750 | 15,949 | 12,241 |
Revenue (Total) Revenue (Total) Growth | 56,693 | 56,674 | 51,722 | 46,660 | 43,461 | 43,974 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 7,690 | 11,590 | 13,457 | 14,428 | 18,930 | 28,329 |
Total Debt Total Debt Growth | 49,014 | 35,457 | 31,401 | 26,439 | 27,964 | 31,093 |
Net Cash (Debt) Net Cash Growth | -41,324 | -23,867 | -17,944 | -12,011 | -9,034 | -2,764 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -21.47 | -12.21 | -8.82 | -5.74 | -4.11 | -1.22 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 18,393 | 19,144 | 17,619 | 14,458 | 14,236 | 15,071 |
Capital Expenditures CapEx Growth | -1,630 | -1,548 | -1,366 | -1,060 | -916 | -1,066 |
Free Cash Flow Free Cash Flow Growth | 16,763 | 17,596 | 16,253 | 13,398 | 13,320 | 14,005 |
Free Cash Flow Growth | -13.25% | 8.26% | 21.31% | 0.59% | -4.89% | 13.17% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 74.74% | 75.83% | 75.20% | 73.27% | 73.35% | 73.31% |
Operating Margin | 30.17% | 31.13% | 28.12% | 20.94% | 18.28% | 22.87% |
Pretax Margin | 27.38% | 28.85% | 26.37% | 19.55% | 16.51% | 55.78% |
Profit Margin | 22.48% | 24.64% | 23.08% | 18.37% | 13.92% | 52.09% |
FCF Margin | 29.57% | 31.05% | 31.42% | 28.71% | 30.65% | 31.85% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 7, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 3.081 | 4.666 | 3.862 | 3.919 | 3.461 | 3.401 |
Dividend Per Share Growth | 18.68% | 20.81% | -1.44% | 13.24% | 1.77% | 0.29% |
Dividend Yield | 1.97% | 2.92% | 3.88% | 3.46% | 4.01% | 3.97% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 7, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 23.24 | 19.28 | 16.58 | 14.22 | 27.08 | 7.79 |
P/FCF Ratio | 17.68 | 14.95 | 11.83 | 15.40 | 13.66 | 13.21 |
PS Ratio | 5.23 | 4.64 | 3.72 | 4.42 | 4.19 | 4.21 |